A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia.
Clinical trial NCT06356389 · COMPLETED
Trial details
- NCT number
- NCT06356389
- Sponsor
- Zhejiang Jingxin Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-02
- Primary completion
- 2022-12-27
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.